Were you unable to attend Transform 2022? Check out all of the summit sessions in our on-demand library now! Watch here.
Nobody likes peeing in a cup. But when it comes to urine analysis, that’s the way it’s done.
But Israeli medical device startup Olive Diagnostics has come up with a way to use artificial intelligence to analyze what’s in your toilet bowl — so you don’t have to pee in a cup.
The Jerusalem-based company uses an optical sensor and AI-powered device to perform 100% passive real-time urine analysis. And it is extending its seed funding round to $7.3 million, after raising an additional $1.5 million from existing investors and private investors.
The investors in the pre-seed stage include Israeli HMO Maccabi Healthcare Services, Mayo Clinic, eHealth Ventures, Amgen Ventures, The Israel Innovation Authority, alongside private European and American private investors.
MetaBeat will bring together thought leaders to give guidance on how metaverse technology will transform the way all industries communicate and do business on October 4 in San Francisco, CA.
Guy Goldman is CEO of Olive Diagnostics.Olive Diagnostics was founded in 2019 by CEO Guy Goldman and Corey Katz. The startup’s team includes experts in biochemistry, chemistry, physics, data analytics, optics, and business development for the health and wellness markets.
Olive Diagnostics’ flagship product, Olive KG, is the world’s first AI- and spectroscopy-based device, which performs high-quality analysis of important parameters in the patients’ urine in each urination, in a 100% passive way and without any need for additional accessories. (Yes, no pee cups).
Among other parameters, the device measures red blood cells, proteins, ketones, Nitrite, pH, alongside features such as volume, pressure, color and frequency of urination. No longer do you have to go to the doctor’s office to provide a urine sample, or send it away in the mail before you get results much later.
Olive KG is an IoMT (Internet of Medical Things) device and can be mounted on any toilet. It uses optics to detect the chemical components in the urine, and generates real-time personal data. That data is secured according to GDPR and HIPPA (privacy and health-related regulations) requirements, which are sent to the cloud and then to the treating doctor.
Olive Diagnostics has received the EU’s CE Marking for Olive KG as a medical device. Following the approval, Olive received first orders for the product from two European organizations.
“The milestone of receiving the CE Marking provides validation for our vision and technology and paves the way for us to enter the European market,” said Goldman, in a statement. “Olive KG is already installed at several assisted living facilities in Holland, and we believe that our device will transform medical ca …